nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—ACHE—kidney cancer	0.444	0.63	CbGaD
Pyridostigmine—BCHE—kidney cancer	0.261	0.37	CbGaD
Pyridostigmine—CYP3A4—Everolimus—kidney cancer	0.0531	0.293	CbGbCtD
Pyridostigmine—CYP3A4—Temsirolimus—kidney cancer	0.0359	0.198	CbGbCtD
Pyridostigmine—CYP3A4—Pazopanib—kidney cancer	0.0189	0.104	CbGbCtD
Pyridostigmine—CYP3A4—Erlotinib—kidney cancer	0.0135	0.0741	CbGbCtD
Pyridostigmine—CYP3A4—Paclitaxel—kidney cancer	0.0123	0.0678	CbGbCtD
Pyridostigmine—CYP3A4—Sorafenib—kidney cancer	0.0109	0.0603	CbGbCtD
Pyridostigmine—CYP3A4—Vinblastine—kidney cancer	0.0108	0.0595	CbGbCtD
Pyridostigmine—CYP3A4—Vincristine—kidney cancer	0.0106	0.0585	CbGbCtD
Pyridostigmine—CYP3A4—Sunitinib—kidney cancer	0.00886	0.0488	CbGbCtD
Pyridostigmine—CYP3A4—Doxorubicin—kidney cancer	0.00664	0.0366	CbGbCtD
Pyridostigmine—Rivastigmine—ACHE—kidney cancer	0.00185	0.294	CrCbGaD
Pyridostigmine—Neostigmine—ACHE—kidney cancer	0.00185	0.294	CrCbGaD
Pyridostigmine—Rivastigmine—BCHE—kidney cancer	0.00109	0.173	CrCbGaD
Pyridostigmine—Neostigmine—BCHE—kidney cancer	0.00109	0.173	CrCbGaD
Pyridostigmine—Neostigmine—ABCB1—kidney cancer	0.000427	0.0676	CrCbGaD
Pyridostigmine—Abdominal pain—Temsirolimus—kidney cancer	0.000302	0.00337	CcSEcCtD
Pyridostigmine—Convulsion—Everolimus—kidney cancer	0.000301	0.00336	CcSEcCtD
Pyridostigmine—Dry skin—Paclitaxel—kidney cancer	0.000297	0.00331	CcSEcCtD
Pyridostigmine—Myalgia—Everolimus—kidney cancer	0.000296	0.0033	CcSEcCtD
Pyridostigmine—Loss of consciousness—Erlotinib—kidney cancer	0.000295	0.00329	CcSEcCtD
Pyridostigmine—Alopecia—Sunitinib—kidney cancer	0.000295	0.00329	CcSEcCtD
Pyridostigmine—Eye pain—Capecitabine—kidney cancer	0.000294	0.00329	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Pazopanib—kidney cancer	0.000294	0.00328	CcSEcCtD
Pyridostigmine—Cramp muscle—Paclitaxel—kidney cancer	0.000292	0.00326	CcSEcCtD
Pyridostigmine—Muscle spasms—Sorafenib—kidney cancer	0.00029	0.00324	CcSEcCtD
Pyridostigmine—Flatulence—Sunitinib—kidney cancer	0.000286	0.00319	CcSEcCtD
Pyridostigmine—Myalgia—Erlotinib—kidney cancer	0.000286	0.00319	CcSEcCtD
Pyridostigmine—Abdominal pain—Pazopanib—kidney cancer	0.000284	0.00317	CcSEcCtD
Pyridostigmine—Abdominal distension—Paclitaxel—kidney cancer	0.000282	0.00315	CcSEcCtD
Pyridostigmine—Hypersensitivity—Temsirolimus—kidney cancer	0.000281	0.00314	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Vincristine—kidney cancer	0.000281	0.00313	CcSEcCtD
Pyridostigmine—Muscle spasms—Sunitinib—kidney cancer	0.000279	0.00312	CcSEcCtD
Pyridostigmine—Alopecia—Dactinomycin—kidney cancer	0.000279	0.00311	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Everolimus—kidney cancer	0.000274	0.00306	CcSEcCtD
Pyridostigmine—Asthenia—Temsirolimus—kidney cancer	0.000274	0.00305	CcSEcCtD
Pyridostigmine—Sweating increased—Paclitaxel—kidney cancer	0.000273	0.00304	CcSEcCtD
Pyridostigmine—Lethargy—Capecitabine—kidney cancer	0.000271	0.00303	CcSEcCtD
Pyridostigmine—Bronchitis—Paclitaxel—kidney cancer	0.000269	0.00301	CcSEcCtD
Pyridostigmine—Loss of consciousness—Sorafenib—kidney cancer	0.000265	0.00296	CcSEcCtD
Pyridostigmine—Hypotension—Everolimus—kidney cancer	0.000265	0.00296	CcSEcCtD
Pyridostigmine—Diarrhoea—Temsirolimus—kidney cancer	0.000261	0.00291	CcSEcCtD
Pyridostigmine—Pollakiuria—Paclitaxel—kidney cancer	0.000259	0.00289	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Everolimus—kidney cancer	0.000258	0.00289	CcSEcCtD
Pyridostigmine—Asthenia—Pazopanib—kidney cancer	0.000258	0.00288	CcSEcCtD
Pyridostigmine—Myalgia—Sorafenib—kidney cancer	0.000257	0.00287	CcSEcCtD
Pyridostigmine—Lacrimation increased—Doxorubicin—kidney cancer	0.000256	0.00286	CcSEcCtD
Pyridostigmine—Paraesthesia—Vinblastine—kidney cancer	0.000256	0.00285	CcSEcCtD
Pyridostigmine—Paraesthesia—Everolimus—kidney cancer	0.000255	0.00284	CcSEcCtD
Pyridostigmine—Cardiac arrest—Capecitabine—kidney cancer	0.000253	0.00282	CcSEcCtD
Pyridostigmine—Somnolence—Everolimus—kidney cancer	0.000252	0.00282	CcSEcCtD
Pyridostigmine—Convulsion—Sunitinib—kidney cancer	0.000252	0.00281	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Erlotinib—kidney cancer	0.000249	0.00278	CcSEcCtD
Pyridostigmine—Alopecia—Vincristine—kidney cancer	0.000249	0.00278	CcSEcCtD
Pyridostigmine—Myalgia—Sunitinib—kidney cancer	0.000247	0.00276	CcSEcCtD
Pyridostigmine—Diarrhoea—Pazopanib—kidney cancer	0.000246	0.00274	CcSEcCtD
Pyridostigmine—Dry skin—Capecitabine—kidney cancer	0.000244	0.00272	CcSEcCtD
Pyridostigmine—Vomiting—Temsirolimus—kidney cancer	0.000243	0.00271	CcSEcCtD
Pyridostigmine—Rash—Temsirolimus—kidney cancer	0.00024	0.00268	CcSEcCtD
Pyridostigmine—Dermatitis—Temsirolimus—kidney cancer	0.00024	0.00268	CcSEcCtD
Pyridostigmine—Headache—Temsirolimus—kidney cancer	0.000239	0.00267	CcSEcCtD
Pyridostigmine—Neck pain—Doxorubicin—kidney cancer	0.000239	0.00267	CcSEcCtD
Pyridostigmine—Alopecia—Gemcitabine—kidney cancer	0.000237	0.00264	CcSEcCtD
Pyridostigmine—Epistaxis—Paclitaxel—kidney cancer	0.000235	0.00263	CcSEcCtD
Pyridostigmine—Feeling abnormal—Vinblastine—kidney cancer	0.000235	0.00262	CcSEcCtD
Pyridostigmine—Myalgia—Dactinomycin—kidney cancer	0.000234	0.00261	CcSEcCtD
Pyridostigmine—Feeling abnormal—Everolimus—kidney cancer	0.000234	0.00261	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Vinblastine—kidney cancer	0.000233	0.0026	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Everolimus—kidney cancer	0.000232	0.00259	CcSEcCtD
Pyridostigmine—Abdominal distension—Capecitabine—kidney cancer	0.000231	0.00258	CcSEcCtD
Pyridostigmine—Asthma—Capecitabine—kidney cancer	0.00023	0.00256	CcSEcCtD
Pyridostigmine—Salivary hypersecretion—Doxorubicin—kidney cancer	0.000229	0.00256	CcSEcCtD
Pyridostigmine—Vomiting—Pazopanib—kidney cancer	0.000228	0.00255	CcSEcCtD
Pyridostigmine—Bradycardia—Paclitaxel—kidney cancer	0.000228	0.00255	CcSEcCtD
Pyridostigmine—Rash—Pazopanib—kidney cancer	0.000227	0.00253	CcSEcCtD
Pyridostigmine—Nausea—Temsirolimus—kidney cancer	0.000227	0.00253	CcSEcCtD
Pyridostigmine—Dermatitis—Pazopanib—kidney cancer	0.000226	0.00253	CcSEcCtD
Pyridostigmine—Agitation—Vincristine—kidney cancer	0.000226	0.00252	CcSEcCtD
Pyridostigmine—Abdominal pain—Vinblastine—kidney cancer	0.000225	0.00251	CcSEcCtD
Pyridostigmine—Headache—Pazopanib—kidney cancer	0.000225	0.00251	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Sorafenib—kidney cancer	0.000224	0.0025	CcSEcCtD
Pyridostigmine—Abdominal pain—Everolimus—kidney cancer	0.000224	0.0025	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Erlotinib—kidney cancer	0.000224	0.0025	CcSEcCtD
Pyridostigmine—Sweating increased—Capecitabine—kidney cancer	0.000224	0.0025	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Paclitaxel—kidney cancer	0.000223	0.00249	CcSEcCtD
Pyridostigmine—Bronchitis—Capecitabine—kidney cancer	0.000221	0.00247	CcSEcCtD
Pyridostigmine—Vertigo—Vincristine—kidney cancer	0.000221	0.00246	CcSEcCtD
Pyridostigmine—Abdominal pain—Erlotinib—kidney cancer	0.000216	0.00242	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Sunitinib—kidney cancer	0.000216	0.00241	CcSEcCtD
Pyridostigmine—Nausea—Pazopanib—kidney cancer	0.000213	0.00238	CcSEcCtD
Pyridostigmine—Paraesthesia—Sunitinib—kidney cancer	0.000213	0.00238	CcSEcCtD
Pyridostigmine—Convulsion—Vincristine—kidney cancer	0.000213	0.00238	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Doxorubicin—kidney cancer	0.00021	0.00235	CcSEcCtD
Pyridostigmine—Hypersensitivity—Vinblastine—kidney cancer	0.00021	0.00234	CcSEcCtD
Pyridostigmine—Myalgia—Vincristine—kidney cancer	0.000209	0.00233	CcSEcCtD
Pyridostigmine—Hypersensitivity—Everolimus—kidney cancer	0.000209	0.00233	CcSEcCtD
Pyridostigmine—Hypertonia—Doxorubicin—kidney cancer	0.000207	0.00231	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—JUNB—kidney cancer	0.000206	0.0116	CbGpPWpGaD
Pyridostigmine—Musculoskeletal discomfort—Dactinomycin—kidney cancer	0.000204	0.00228	CcSEcCtD
Pyridostigmine—Asthenia—Vinblastine—kidney cancer	0.000204	0.00228	CcSEcCtD
Pyridostigmine—Asthenia—Everolimus—kidney cancer	0.000204	0.00227	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Sorafenib—kidney cancer	0.000201	0.00225	CcSEcCtD
Pyridostigmine—Myalgia—Gemcitabine—kidney cancer	0.000198	0.00221	CcSEcCtD
Pyridostigmine—Alopecia—Paclitaxel—kidney cancer	0.000198	0.00221	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Doxorubicin—kidney cancer	0.000198	0.00221	CcSEcCtD
Pyridostigmine—Asthenia—Erlotinib—kidney cancer	0.000196	0.00219	CcSEcCtD
Pyridostigmine—Urticaria—Sorafenib—kidney cancer	0.000196	0.00218	CcSEcCtD
Pyridostigmine—Diarrhoea—Vinblastine—kidney cancer	0.000195	0.00218	CcSEcCtD
Pyridostigmine—Abdominal pain—Sorafenib—kidney cancer	0.000195	0.00217	CcSEcCtD
Pyridostigmine—Diarrhoea—Everolimus—kidney cancer	0.000194	0.00217	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Sunitinib—kidney cancer	0.000194	0.00216	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Vincristine—kidney cancer	0.000194	0.00216	CcSEcCtD
Pyridostigmine—Epistaxis—Capecitabine—kidney cancer	0.000193	0.00216	CcSEcCtD
Pyridostigmine—Flatulence—Paclitaxel—kidney cancer	0.000192	0.00215	CcSEcCtD
Pyridostigmine—Eye pain—Doxorubicin—kidney cancer	0.00019	0.00212	CcSEcCtD
Pyridostigmine—Muscle spasms—Paclitaxel—kidney cancer	0.000188	0.00209	CcSEcCtD
Pyridostigmine—Abdominal pain—Sunitinib—kidney cancer	0.000187	0.00209	CcSEcCtD
Pyridostigmine—Diarrhoea—Erlotinib—kidney cancer	0.000187	0.00209	CcSEcCtD
Pyridostigmine—Hypotension—Vincristine—kidney cancer	0.000187	0.00209	CcSEcCtD
Pyridostigmine—Bradycardia—Capecitabine—kidney cancer	0.000187	0.00209	CcSEcCtD
Pyridostigmine—Feeling abnormal—Dactinomycin—kidney cancer	0.000185	0.00206	CcSEcCtD
Pyridostigmine—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000185	0.0104	CbGpPWpGaD
Pyridostigmine—Hyperhidrosis—Gemcitabine—kidney cancer	0.000184	0.00205	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000183	0.00205	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Capecitabine—kidney cancer	0.000183	0.00204	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000183	0.00204	CcSEcCtD
Pyridostigmine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000182	0.0102	CbGpPWpGaD
Pyridostigmine—Hypersensitivity—Sorafenib—kidney cancer	0.000181	0.00203	CcSEcCtD
Pyridostigmine—Vomiting—Vinblastine—kidney cancer	0.000181	0.00202	CcSEcCtD
Pyridostigmine—Vomiting—Everolimus—kidney cancer	0.00018	0.00201	CcSEcCtD
Pyridostigmine—Paraesthesia—Vincristine—kidney cancer	0.00018	0.00201	CcSEcCtD
Pyridostigmine—Agitation—Paclitaxel—kidney cancer	0.000179	0.002	CcSEcCtD
Pyridostigmine—Rash—Everolimus—kidney cancer	0.000179	0.002	CcSEcCtD
Pyridostigmine—Dermatitis—Everolimus—kidney cancer	0.000179	0.00199	CcSEcCtD
Pyridostigmine—Headache—Vinblastine—kidney cancer	0.000178	0.00199	CcSEcCtD
Pyridostigmine—Headache—Everolimus—kidney cancer	0.000178	0.00198	CcSEcCtD
Pyridostigmine—Hypotension—Gemcitabine—kidney cancer	0.000178	0.00198	CcSEcCtD
Pyridostigmine—ACHE—Peptide hormone metabolism—PAX6—kidney cancer	0.000178	0.00998	CbGpPWpGaD
Pyridostigmine—Abdominal pain—Dactinomycin—kidney cancer	0.000177	0.00198	CcSEcCtD
Pyridostigmine—Asthenia—Sorafenib—kidney cancer	0.000177	0.00197	CcSEcCtD
Pyridostigmine—ACHE—Peptide hormone metabolism—CTSD—kidney cancer	0.000177	0.00992	CbGpPWpGaD
Pyridostigmine—Vertigo—Paclitaxel—kidney cancer	0.000175	0.00196	CcSEcCtD
Pyridostigmine—Lethargy—Doxorubicin—kidney cancer	0.000175	0.00195	CcSEcCtD
Pyridostigmine—Hypersensitivity—Sunitinib—kidney cancer	0.000175	0.00195	CcSEcCtD
Pyridostigmine—Vomiting—Erlotinib—kidney cancer	0.000174	0.00194	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000173	0.00193	CcSEcCtD
Pyridostigmine—Rash—Erlotinib—kidney cancer	0.000173	0.00193	CcSEcCtD
Pyridostigmine—Dermatitis—Erlotinib—kidney cancer	0.000172	0.00192	CcSEcCtD
Pyridostigmine—Headache—Erlotinib—kidney cancer	0.000172	0.00191	CcSEcCtD
Pyridostigmine—Loss of consciousness—Paclitaxel—kidney cancer	0.000171	0.00191	CcSEcCtD
Pyridostigmine—Paraesthesia—Gemcitabine—kidney cancer	0.000171	0.00191	CcSEcCtD
Pyridostigmine—Asthenia—Sunitinib—kidney cancer	0.00017	0.0019	CcSEcCtD
Pyridostigmine—Nausea—Vinblastine—kidney cancer	0.000169	0.00189	CcSEcCtD
Pyridostigmine—Somnolence—Gemcitabine—kidney cancer	0.000169	0.00189	CcSEcCtD
Pyridostigmine—Convulsion—Paclitaxel—kidney cancer	0.000169	0.00189	CcSEcCtD
Pyridostigmine—Nausea—Everolimus—kidney cancer	0.000169	0.00188	CcSEcCtD
Pyridostigmine—Diarrhoea—Sorafenib—kidney cancer	0.000169	0.00188	CcSEcCtD
Pyridostigmine—BCHE—Peptide hormone metabolism—ACHE—kidney cancer	0.000166	0.00935	CbGpPWpGaD
Pyridostigmine—Myalgia—Paclitaxel—kidney cancer	0.000166	0.00185	CcSEcCtD
Pyridostigmine—Hypersensitivity—Dactinomycin—kidney cancer	0.000165	0.00184	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Vincristine—kidney cancer	0.000164	0.00183	CcSEcCtD
Pyridostigmine—Cardiac arrest—Doxorubicin—kidney cancer	0.000163	0.00182	CcSEcCtD
Pyridostigmine—Nausea—Erlotinib—kidney cancer	0.000163	0.00181	CcSEcCtD
Pyridostigmine—ACHE—Peptide hormone metabolism—BCHE—kidney cancer	0.000163	0.00913	CbGpPWpGaD
Pyridostigmine—Alopecia—Capecitabine—kidney cancer	0.000163	0.00181	CcSEcCtD
Pyridostigmine—Diarrhoea—Sunitinib—kidney cancer	0.000162	0.00181	CcSEcCtD
Pyridostigmine—BCHE—Glycerophospholipid biosynthesis—ACHE—kidney cancer	0.000162	0.0091	CbGpPWpGaD
Pyridostigmine—Asthenia—Dactinomycin—kidney cancer	0.000161	0.0018	CcSEcCtD
Pyridostigmine—Confusional state—Paclitaxel—kidney cancer	0.000161	0.00179	CcSEcCtD
Pyridostigmine—Abdominal pain—Vincristine—kidney cancer	0.000158	0.00177	CcSEcCtD
Pyridostigmine—BCHE—Peptide hormone metabolism—PAX6—kidney cancer	0.000158	0.0089	CbGpPWpGaD
Pyridostigmine—ACHE—Glycerophospholipid biosynthesis—BCHE—kidney cancer	0.000158	0.00888	CbGpPWpGaD
Pyridostigmine—Flatulence—Capecitabine—kidney cancer	0.000158	0.00176	CcSEcCtD
Pyridostigmine—BCHE—Peptide hormone metabolism—CTSD—kidney cancer	0.000158	0.00885	CbGpPWpGaD
Pyridostigmine—Dry skin—Doxorubicin—kidney cancer	0.000157	0.00175	CcSEcCtD
Pyridostigmine—Feeling abnormal—Gemcitabine—kidney cancer	0.000157	0.00175	CcSEcCtD
Pyridostigmine—Vomiting—Sorafenib—kidney cancer	0.000157	0.00175	CcSEcCtD
Pyridostigmine—Rash—Sorafenib—kidney cancer	0.000155	0.00173	CcSEcCtD
Pyridostigmine—Dermatitis—Sorafenib—kidney cancer	0.000155	0.00173	CcSEcCtD
Pyridostigmine—Headache—Sorafenib—kidney cancer	0.000154	0.00172	CcSEcCtD
Pyridostigmine—Muscle spasms—Capecitabine—kidney cancer	0.000154	0.00172	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000154	0.00172	CcSEcCtD
Pyridostigmine—Diarrhoea—Dactinomycin—kidney cancer	0.000154	0.00171	CcSEcCtD
Pyridostigmine—Vomiting—Sunitinib—kidney cancer	0.000151	0.00168	CcSEcCtD
Pyridostigmine—Rash—Sunitinib—kidney cancer	0.000149	0.00167	CcSEcCtD
Pyridostigmine—Dermatitis—Sunitinib—kidney cancer	0.000149	0.00167	CcSEcCtD
Pyridostigmine—Abdominal distension—Doxorubicin—kidney cancer	0.000149	0.00166	CcSEcCtD
Pyridostigmine—Hypotension—Paclitaxel—kidney cancer	0.000149	0.00166	CcSEcCtD
Pyridostigmine—Headache—Sunitinib—kidney cancer	0.000148	0.00166	CcSEcCtD
Pyridostigmine—Asthma—Doxorubicin—kidney cancer	0.000148	0.00165	CcSEcCtD
Pyridostigmine—Hypersensitivity—Vincristine—kidney cancer	0.000148	0.00165	CcSEcCtD
Pyridostigmine—Nausea—Sorafenib—kidney cancer	0.000146	0.00163	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000145	0.00162	CcSEcCtD
Pyridostigmine—Vertigo—Capecitabine—kidney cancer	0.000144	0.00161	CcSEcCtD
Pyridostigmine—Asthenia—Vincristine—kidney cancer	0.000144	0.00161	CcSEcCtD
Pyridostigmine—Paraesthesia—Paclitaxel—kidney cancer	0.000143	0.0016	CcSEcCtD
Pyridostigmine—Vomiting—Dactinomycin—kidney cancer	0.000143	0.00159	CcSEcCtD
Pyridostigmine—Bronchitis—Doxorubicin—kidney cancer	0.000142	0.00159	CcSEcCtD
Pyridostigmine—Somnolence—Paclitaxel—kidney cancer	0.000142	0.00158	CcSEcCtD
Pyridostigmine—Rash—Dactinomycin—kidney cancer	0.000141	0.00158	CcSEcCtD
Pyridostigmine—Nausea—Sunitinib—kidney cancer	0.000141	0.00157	CcSEcCtD
Pyridostigmine—Loss of consciousness—Capecitabine—kidney cancer	0.000141	0.00157	CcSEcCtD
Pyridostigmine—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000139	0.00782	CbGpPWpGaD
Pyridostigmine—Diarrhoea—Vincristine—kidney cancer	0.000137	0.00153	CcSEcCtD
Pyridostigmine—Pollakiuria—Doxorubicin—kidney cancer	0.000137	0.00153	CcSEcCtD
Pyridostigmine—Asthenia—Gemcitabine—kidney cancer	0.000136	0.00152	CcSEcCtD
Pyridostigmine—Myalgia—Capecitabine—kidney cancer	0.000136	0.00152	CcSEcCtD
Pyridostigmine—Nausea—Dactinomycin—kidney cancer	0.000133	0.00149	CcSEcCtD
Pyridostigmine—Drowsiness—Doxorubicin—kidney cancer	0.000132	0.00147	CcSEcCtD
Pyridostigmine—Confusional state—Capecitabine—kidney cancer	0.000132	0.00147	CcSEcCtD
Pyridostigmine—Feeling abnormal—Paclitaxel—kidney cancer	0.000131	0.00146	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00013	0.00145	CcSEcCtD
Pyridostigmine—Diarrhoea—Gemcitabine—kidney cancer	0.00013	0.00145	CcSEcCtD
Pyridostigmine—Vomiting—Vincristine—kidney cancer	0.000127	0.00142	CcSEcCtD
Pyridostigmine—Urticaria—Paclitaxel—kidney cancer	0.000126	0.00141	CcSEcCtD
Pyridostigmine—Rash—Vincristine—kidney cancer	0.000126	0.00141	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Capecitabine—kidney cancer	0.000126	0.00141	CcSEcCtD
Pyridostigmine—Dermatitis—Vincristine—kidney cancer	0.000126	0.00141	CcSEcCtD
Pyridostigmine—Abdominal pain—Paclitaxel—kidney cancer	0.000126	0.0014	CcSEcCtD
Pyridostigmine—Headache—Vincristine—kidney cancer	0.000126	0.0014	CcSEcCtD
Pyridostigmine—Epistaxis—Doxorubicin—kidney cancer	0.000125	0.00139	CcSEcCtD
Pyridostigmine—Hypotension—Capecitabine—kidney cancer	0.000122	0.00136	CcSEcCtD
Pyridostigmine—Vomiting—Gemcitabine—kidney cancer	0.000121	0.00135	CcSEcCtD
Pyridostigmine—Bradycardia—Doxorubicin—kidney cancer	0.000121	0.00135	CcSEcCtD
Pyridostigmine—Rash—Gemcitabine—kidney cancer	0.00012	0.00134	CcSEcCtD
Pyridostigmine—Dermatitis—Gemcitabine—kidney cancer	0.00012	0.00134	CcSEcCtD
Pyridostigmine—Headache—Gemcitabine—kidney cancer	0.000119	0.00133	CcSEcCtD
Pyridostigmine—Nausea—Vincristine—kidney cancer	0.000119	0.00133	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000119	0.00133	CcSEcCtD
Pyridostigmine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000119	0.00668	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	0.000118	0.00665	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	0.000118	0.00665	CbGpPWpGaD
Pyridostigmine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000118	0.00132	CcSEcCtD
Pyridostigmine—Paraesthesia—Capecitabine—kidney cancer	0.000117	0.00131	CcSEcCtD
Pyridostigmine—Hypersensitivity—Paclitaxel—kidney cancer	0.000117	0.00131	CcSEcCtD
Pyridostigmine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000115	0.00646	CbGpPWpGaD
Pyridostigmine—Asthenia—Paclitaxel—kidney cancer	0.000114	0.00127	CcSEcCtD
Pyridostigmine—BCHE—Phospholipid metabolism—ACHE—kidney cancer	0.000113	0.00635	CbGpPWpGaD
Pyridostigmine—Nausea—Gemcitabine—kidney cancer	0.000113	0.00126	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	0.000112	0.00631	CbGpPWpGaD
Pyridostigmine—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.00011	0.0062	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—BCHE—kidney cancer	0.00011	0.0062	CbGpPWpGaD
Pyridostigmine—Diarrhoea—Paclitaxel—kidney cancer	0.000109	0.00122	CcSEcCtD
Pyridostigmine—Feeling abnormal—Capecitabine—kidney cancer	0.000108	0.0012	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000107	0.00119	CcSEcCtD
Pyridostigmine—Alopecia—Doxorubicin—kidney cancer	0.000105	0.00117	CcSEcCtD
Pyridostigmine—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000105	0.00588	CbGpPWpGaD
Pyridostigmine—Urticaria—Capecitabine—kidney cancer	0.000104	0.00116	CcSEcCtD
Pyridostigmine—Abdominal pain—Capecitabine—kidney cancer	0.000103	0.00115	CcSEcCtD
Pyridostigmine—Flatulence—Doxorubicin—kidney cancer	0.000102	0.00113	CcSEcCtD
Pyridostigmine—Vomiting—Paclitaxel—kidney cancer	0.000101	0.00113	CcSEcCtD
Pyridostigmine—Rash—Paclitaxel—kidney cancer	0.0001	0.00112	CcSEcCtD
Pyridostigmine—Dermatitis—Paclitaxel—kidney cancer	0.0001	0.00112	CcSEcCtD
Pyridostigmine—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.0001	0.00563	CbGpPWpGaD
Pyridostigmine—Headache—Paclitaxel—kidney cancer	9.97e-05	0.00111	CcSEcCtD
Pyridostigmine—Muscle spasms—Doxorubicin—kidney cancer	9.92e-05	0.00111	CcSEcCtD
Pyridostigmine—ACHE—Neuronal System—KCNMA1—kidney cancer	9.75e-05	0.00548	CbGpPWpGaD
Pyridostigmine—Hypersensitivity—Capecitabine—kidney cancer	9.63e-05	0.00107	CcSEcCtD
Pyridostigmine—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	9.62e-05	0.0054	CbGpPWpGaD
Pyridostigmine—Agitation—Doxorubicin—kidney cancer	9.48e-05	0.00106	CcSEcCtD
Pyridostigmine—Nausea—Paclitaxel—kidney cancer	9.46e-05	0.00106	CcSEcCtD
Pyridostigmine—Asthenia—Capecitabine—kidney cancer	9.37e-05	0.00105	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of proteins—EIF5B—kidney cancer	9.3e-05	0.00523	CbGpPWpGaD
Pyridostigmine—Vertigo—Doxorubicin—kidney cancer	9.27e-05	0.00103	CcSEcCtD
Pyridostigmine—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	9.25e-05	0.0052	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	9.12e-05	0.00512	CbGpPWpGaD
Pyridostigmine—Loss of consciousness—Doxorubicin—kidney cancer	9.07e-05	0.00101	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	8.97e-05	0.00504	CbGpPWpGaD
Pyridostigmine—Convulsion—Doxorubicin—kidney cancer	8.94e-05	0.000998	CcSEcCtD
Pyridostigmine—Diarrhoea—Capecitabine—kidney cancer	8.94e-05	0.000998	CcSEcCtD
Pyridostigmine—CYP3A4—Biological oxidations—ACY1—kidney cancer	8.84e-05	0.00497	CbGpPWpGaD
Pyridostigmine—Myalgia—Doxorubicin—kidney cancer	8.79e-05	0.000981	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	8.78e-05	0.00493	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—KCNMA1—kidney cancer	8.7e-05	0.00489	CbGpPWpGaD
Pyridostigmine—Confusional state—Doxorubicin—kidney cancer	8.49e-05	0.000948	CcSEcCtD
Pyridostigmine—ACHE—Peptide hormone metabolism—POMC—kidney cancer	8.4e-05	0.00472	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—ACHE—kidney cancer	8.4e-05	0.00472	CbGpPWpGaD
Pyridostigmine—Vomiting—Capecitabine—kidney cancer	8.31e-05	0.000927	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of proteins—EIF5B—kidney cancer	8.3e-05	0.00466	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CUL7—kidney cancer	8.29e-05	0.00466	CbGpPWpGaD
Pyridostigmine—Rash—Capecitabine—kidney cancer	8.24e-05	0.000919	CcSEcCtD
Pyridostigmine—Dermatitis—Capecitabine—kidney cancer	8.23e-05	0.000919	CcSEcCtD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—BCHE—kidney cancer	8.2e-05	0.00461	CbGpPWpGaD
Pyridostigmine—Headache—Capecitabine—kidney cancer	8.18e-05	0.000914	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Doxorubicin—kidney cancer	8.14e-05	0.000909	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—CCND1—kidney cancer	8.11e-05	0.00456	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—JUN—kidney cancer	8.09e-05	0.00455	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	8.06e-05	0.00453	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	8.06e-05	0.00453	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—HSPA9—kidney cancer	7.91e-05	0.00444	CbGpPWpGaD
Pyridostigmine—Hypotension—Doxorubicin—kidney cancer	7.87e-05	0.000878	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	7.83e-05	0.0044	CbGpPWpGaD
Pyridostigmine—Nausea—Capecitabine—kidney cancer	7.76e-05	0.000866	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	7.67e-05	0.000856	CcSEcCtD
Pyridostigmine—Paraesthesia—Doxorubicin—kidney cancer	7.56e-05	0.000844	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	7.54e-05	0.00423	CbGpPWpGaD
Pyridostigmine—BCHE—Peptide hormone metabolism—POMC—kidney cancer	7.5e-05	0.00421	CbGpPWpGaD
Pyridostigmine—Somnolence—Doxorubicin—kidney cancer	7.49e-05	0.000836	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of proteins—CUL7—kidney cancer	7.4e-05	0.00416	CbGpPWpGaD
Pyridostigmine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	7.17e-05	0.00403	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—HSPA9—kidney cancer	7.06e-05	0.00396	CbGpPWpGaD
Pyridostigmine—Feeling abnormal—Doxorubicin—kidney cancer	6.94e-05	0.000775	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Doxorubicin—kidney cancer	6.89e-05	0.000769	CcSEcCtD
Pyridostigmine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	6.83e-05	0.00384	CbGpPWpGaD
Pyridostigmine—Urticaria—Doxorubicin—kidney cancer	6.69e-05	0.000747	CcSEcCtD
Pyridostigmine—ACHE—ATF-2 transcription factor network—MAPK3—kidney cancer	6.69e-05	0.00376	CbGpPWpGaD
Pyridostigmine—Abdominal pain—Doxorubicin—kidney cancer	6.66e-05	0.000743	CcSEcCtD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	6.62e-05	0.00372	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	6.56e-05	0.00368	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—MUC4—kidney cancer	6.45e-05	0.00362	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—ACHE—kidney cancer	6.43e-05	0.00361	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	6.41e-05	0.0036	CbGpPWpGaD
Pyridostigmine—ACHE—ATF-2 transcription factor network—MAPK1—kidney cancer	6.36e-05	0.00357	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—BCHE—kidney cancer	6.28e-05	0.00353	CbGpPWpGaD
Pyridostigmine—Hypersensitivity—Doxorubicin—kidney cancer	6.2e-05	0.000693	CcSEcCtD
Pyridostigmine—ACHE—Metabolism of proteins—ST3GAL2—kidney cancer	6.13e-05	0.00345	CbGpPWpGaD
Pyridostigmine—Asthenia—Doxorubicin—kidney cancer	6.04e-05	0.000674	CcSEcCtD
Pyridostigmine—ACHE—Peptide hormone metabolism—CTNNB1—kidney cancer	6e-05	0.00337	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—EEF2—kidney cancer	6e-05	0.00337	CbGpPWpGaD
Pyridostigmine—Diarrhoea—Doxorubicin—kidney cancer	5.76e-05	0.000643	CcSEcCtD
Pyridostigmine—BCHE—Metabolism of proteins—MUC4—kidney cancer	5.75e-05	0.00323	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ACY1—kidney cancer	5.64e-05	0.00317	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—ST3GAL2—kidney cancer	5.47e-05	0.00307	CbGpPWpGaD
Pyridostigmine—Vomiting—Doxorubicin—kidney cancer	5.35e-05	0.000598	CcSEcCtD
Pyridostigmine—BCHE—Peptide hormone metabolism—CTNNB1—kidney cancer	5.35e-05	0.00301	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—EEF2—kidney cancer	5.35e-05	0.003	CbGpPWpGaD
Pyridostigmine—Rash—Doxorubicin—kidney cancer	5.31e-05	0.000593	CcSEcCtD
Pyridostigmine—Dermatitis—Doxorubicin—kidney cancer	5.31e-05	0.000592	CcSEcCtD
Pyridostigmine—Headache—Doxorubicin—kidney cancer	5.28e-05	0.000589	CcSEcCtD
Pyridostigmine—BCHE—Metabolism—ACY1—kidney cancer	5.03e-05	0.00283	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	5.02e-05	0.00282	CbGpPWpGaD
Pyridostigmine—Nausea—Doxorubicin—kidney cancer	5e-05	0.000558	CcSEcCtD
Pyridostigmine—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	4.94e-05	0.00277	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	4.85e-05	0.00272	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.81e-05	0.0027	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PDHB—kidney cancer	4.8e-05	0.00269	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	4.62e-05	0.00259	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—MME—kidney cancer	4.6e-05	0.00258	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CCBL1—kidney cancer	4.51e-05	0.00253	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	4.29e-05	0.00241	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PDHB—kidney cancer	4.28e-05	0.0024	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—HSPD1—kidney cancer	4.27e-05	0.0024	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—RPL14—kidney cancer	4.27e-05	0.0024	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—BRAF—kidney cancer	4.18e-05	0.00235	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—MME—kidney cancer	4.1e-05	0.0023	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CCBL1—kidney cancer	4.02e-05	0.00226	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	3.99e-05	0.00224	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PTEN—kidney cancer	3.97e-05	0.00223	CbGpPWpGaD
Pyridostigmine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	3.94e-05	0.00221	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GLIPR1—kidney cancer	3.91e-05	0.0022	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PPAT—kidney cancer	3.91e-05	0.0022	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.86e-05	0.00217	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.82e-05	0.00215	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—RPL14—kidney cancer	3.81e-05	0.00214	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—HSPD1—kidney cancer	3.81e-05	0.00214	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—BRAF—kidney cancer	3.73e-05	0.0021	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	3.64e-05	0.00204	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—FH—kidney cancer	3.63e-05	0.00204	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—APRT—kidney cancer	3.63e-05	0.00204	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	3.62e-05	0.00204	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	3.59e-05	0.00201	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	3.55e-05	0.002	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PTEN—kidney cancer	3.54e-05	0.00199	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	3.51e-05	0.00197	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—RAF1—kidney cancer	3.49e-05	0.00196	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GLIPR1—kidney cancer	3.49e-05	0.00196	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PPAT—kidney cancer	3.49e-05	0.00196	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—EIF4EBP1—kidney cancer	3.48e-05	0.00196	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	3.44e-05	0.00193	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GPC3—kidney cancer	3.42e-05	0.00192	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	3.41e-05	0.00191	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—PAX6—kidney cancer	3.35e-05	0.00188	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CTSD—kidney cancer	3.34e-05	0.00187	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CA2—kidney cancer	3.32e-05	0.00187	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	3.32e-05	0.00187	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—FH—kidney cancer	3.24e-05	0.00182	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—APRT—kidney cancer	3.24e-05	0.00182	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ALAD—kidney cancer	3.24e-05	0.00182	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	3.24e-05	0.00182	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—BRAF—kidney cancer	3.21e-05	0.0018	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	3.17e-05	0.00178	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ST3GAL2—kidney cancer	3.16e-05	0.00178	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	3.16e-05	0.00178	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—ACHE—kidney cancer	3.14e-05	0.00177	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	3.14e-05	0.00176	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—RAF1—kidney cancer	3.12e-05	0.00175	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—EIF4EBP1—kidney cancer	3.11e-05	0.00175	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ALDH1A1—kidney cancer	3.09e-05	0.00174	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—BCHE—kidney cancer	3.07e-05	0.00172	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	3.06e-05	0.00172	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GPC3—kidney cancer	3.05e-05	0.00171	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—PAX6—kidney cancer	2.99e-05	0.00168	CbGpPWpGaD
Pyridostigmine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	2.98e-05	0.00167	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—CTSD—kidney cancer	2.98e-05	0.00167	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CA2—kidney cancer	2.97e-05	0.00167	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC5A3—kidney cancer	2.96e-05	0.00166	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PGK1—kidney cancer	2.96e-05	0.00166	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—LDHB—kidney cancer	2.91e-05	0.00163	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ALAD—kidney cancer	2.89e-05	0.00162	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—BRAF—kidney cancer	2.86e-05	0.00161	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	2.85e-05	0.0016	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ST3GAL2—kidney cancer	2.82e-05	0.00158	CbGpPWpGaD
Pyridostigmine—ACHE—Phospholipid metabolism—PIK3CA—kidney cancer	2.8e-05	0.00157	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.76e-05	0.00155	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ALDH1A1—kidney cancer	2.76e-05	0.00155	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—RAF1—kidney cancer	2.68e-05	0.0015	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	2.67e-05	0.0015	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC5A3—kidney cancer	2.64e-05	0.00148	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PGK1—kidney cancer	2.64e-05	0.00148	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.61e-05	0.00147	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—LDHB—kidney cancer	2.59e-05	0.00146	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.54e-05	0.00143	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CA9—kidney cancer	2.52e-05	0.00142	CbGpPWpGaD
Pyridostigmine—BCHE—Phospholipid metabolism—PIK3CA—kidney cancer	2.5e-05	0.0014	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.49e-05	0.0014	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.46e-05	0.00138	CbGpPWpGaD
Pyridostigmine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	2.41e-05	0.00136	CbGpPWpGaD
Pyridostigmine—ACHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.4e-05	0.00135	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—RAF1—kidney cancer	2.39e-05	0.00134	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—IGF2—kidney cancer	2.38e-05	0.00134	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	2.35e-05	0.00132	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CA9—kidney cancer	2.25e-05	0.00126	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.2e-05	0.00123	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	2.16e-05	0.00121	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CRABP1—kidney cancer	2.14e-05	0.0012	CbGpPWpGaD
Pyridostigmine—BCHE—Transmission across Chemical Synapses—MAPK1—kidney cancer	2.14e-05	0.0012	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—IGF2—kidney cancer	2.12e-05	0.00119	CbGpPWpGaD
Pyridostigmine—ACHE—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	2.09e-05	0.00117	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ITPR2—kidney cancer	1.99e-05	0.00112	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	1.97e-05	0.00111	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	1.95e-05	0.00109	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CRABP1—kidney cancer	1.91e-05	0.00107	CbGpPWpGaD
Pyridostigmine—ACHE—Neuronal System—MAPK1—kidney cancer	1.84e-05	0.00103	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.84e-05	0.00103	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTT1—kidney cancer	1.82e-05	0.00102	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	1.81e-05	0.00102	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	1.79e-05	0.001	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ITPR2—kidney cancer	1.78e-05	0.000998	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	1.72e-05	0.000966	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SCARB1—kidney cancer	1.72e-05	0.000966	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTGS1—kidney cancer	1.7e-05	0.000956	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	1.7e-05	0.000953	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PSMD7—kidney cancer	1.67e-05	0.000937	CbGpPWpGaD
Pyridostigmine—BCHE—Neuronal System—MAPK1—kidney cancer	1.64e-05	0.00092	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—POMC—kidney cancer	1.64e-05	0.00092	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ACHE—kidney cancer	1.62e-05	0.00091	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTT1—kidney cancer	1.62e-05	0.00091	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—POMC—kidney cancer	1.59e-05	0.000891	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—BCHE—kidney cancer	1.58e-05	0.000889	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC5A5—kidney cancer	1.56e-05	0.000878	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SCARB1—kidney cancer	1.53e-05	0.000861	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTGS1—kidney cancer	1.52e-05	0.000853	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ACY1—kidney cancer	1.51e-05	0.00085	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—SLC2A1—kidney cancer	1.51e-05	0.000848	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PSMD7—kidney cancer	1.49e-05	0.000836	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.46e-05	0.000823	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—POMC—kidney cancer	1.42e-05	0.000795	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC5A5—kidney cancer	1.39e-05	0.000783	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—SLC2A1—kidney cancer	1.35e-05	0.000756	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.31e-05	0.000734	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PDHB—kidney cancer	1.29e-05	0.000722	CbGpPWpGaD
Pyridostigmine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.28e-05	0.00072	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.28e-05	0.000717	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTP1—kidney cancer	1.26e-05	0.000707	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.21e-05	0.000679	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—ABCB1—kidney cancer	1.19e-05	0.000669	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—GSTM1—kidney cancer	1.16e-05	0.00065	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.14e-05	0.00064	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of proteins—CTNNB1—kidney cancer	1.13e-05	0.000636	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTP1—kidney cancer	1.12e-05	0.000631	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—CYP1A1—kidney cancer	1.1e-05	0.000616	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—ABCB1—kidney cancer	1.06e-05	0.000597	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PPAT—kidney cancer	1.05e-05	0.000589	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.05e-05	0.000589	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—GSTM1—kidney cancer	1.03e-05	0.00058	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of proteins—CTNNB1—kidney cancer	1.01e-05	0.000567	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—CYP1A1—kidney cancer	9.78e-06	0.00055	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—FH—kidney cancer	9.75e-06	0.000548	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—APRT—kidney cancer	9.75e-06	0.000548	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GPC3—kidney cancer	9.16e-06	0.000515	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	9.01e-06	0.000506	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CA2—kidney cancer	8.91e-06	0.000501	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ALAD—kidney cancer	8.69e-06	0.000488	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	8.48e-06	0.000476	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	8.29e-06	0.000466	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—POMC—kidney cancer	8.18e-06	0.000459	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.04e-06	0.000451	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PGK1—kidney cancer	7.95e-06	0.000446	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.95e-06	0.000446	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—LDHB—kidney cancer	7.79e-06	0.000438	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—POMC—kidney cancer	7.29e-06	0.00041	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CA9—kidney cancer	6.76e-06	0.00038	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTGS2—kidney cancer	6.52e-06	0.000366	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTGS2—kidney cancer	5.82e-06	0.000327	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CRABP1—kidney cancer	5.74e-06	0.000323	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PTEN—kidney cancer	5.69e-06	0.000319	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ITPR2—kidney cancer	5.34e-06	0.0003	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PTEN—kidney cancer	5.07e-06	0.000285	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ACHE—kidney cancer	4.87e-06	0.000274	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTT1—kidney cancer	4.87e-06	0.000274	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SCARB1—kidney cancer	4.61e-06	0.000259	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTGS1—kidney cancer	4.56e-06	0.000256	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PSMD7—kidney cancer	4.48e-06	0.000251	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—BCHE—kidney cancer	4.24e-06	0.000238	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC5A5—kidney cancer	4.19e-06	0.000235	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—SLC2A1—kidney cancer	4.05e-06	0.000227	CbGpPWpGaD
Pyridostigmine—ACHE—Metabolism—PIK3CA—kidney cancer	4.01e-06	0.000225	CbGpPWpGaD
Pyridostigmine—BCHE—Metabolism—PIK3CA—kidney cancer	3.58e-06	0.000201	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTP1—kidney cancer	3.38e-06	0.00019	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—ABCB1—kidney cancer	3.2e-06	0.00018	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—GSTM1—kidney cancer	3.1e-06	0.000174	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.94e-06	0.000165	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—POMC—kidney cancer	2.19e-06	0.000123	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.75e-06	9.82e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PTEN—kidney cancer	1.53e-06	8.57e-05	CbGpPWpGaD
Pyridostigmine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.08e-06	6.04e-05	CbGpPWpGaD
